Impact of triple negative phenotype on prognosis of breast cancer patients from a reference cancer unity in the central of Brazil

Authors

  • Reyner Abrantes Stival Pontifícia Universidade Católica de Goiás
  • Luís Roberto de Almeida Martins Pontifícia Universidade Católica de Goiás
  • Junelle Paganini Hospital Araújo Jorge
  • Gustavo Nogueira Caixeta Hospital Araújo Jorge
  • Wilmar Jose Manoel Hospital Araújo Jorge
  • Elbio Cândido de Paula Universidade Federal de Goiás
  • Flavio Monteiro Ayres Universidade Estadual de Goiás
  • Antonio Márcio Teodoro Cordeiro Silva Pontifícia Universidade Católica de Goiás
  • Diego Franciel Marques Mühlbeier Hospital Araújo Jorge
  • Vera Aparecida Saddi Pontifícia Universidade Católica de Goiás

Keywords:

Breast neoplasms, Triple-negative, Prognosis

Abstract

Introduction: Triple-negative breast cancers are tumors that don’t express estrogen receptors, progesterone receptors and HER2. The triple-negative phenotype exhibits more aggressive characteristics, including early onset, high stage on diagnosis, elevated nuclear grade, high mytotic index, agressive patterns of regional and distant metastasis, besides poor prognosis. Objective: To compare the clinical and pathological aspects of a group with 345 breast cancer patients treated in a referral hospital in the center of Brazil, in order to compare the impact of triple-negative phenotype on the patient prognosis. Methods: Patients were selected in the Pathology Laboratory of the institution. Clinical and pathological data were collected from the respective clinical files. Statistical methods comprised univariate analysis and survival curves were generated by using Kaplan-Meier and Log-rank tests. Results: Classic prognostic factors were confirmed for the whole group, including regional lymph nodes metastasis (p<0.001), distant metastasis (p<0.001) and tumor size (p<0.001). By comparing the two groups of breast tumors (TN and NTN), significant statistical differences were observed concerning nuclear grade (p<0.0001) and five year survival (p<0.0001), which varied from 70.3% for NTN patients to 47.1% for TN patients. Conclusion: Our results reinforce the aggressive profile of triple-negative breast cancer that, despite of the classic prognostic factors described for breast cancer, evolves with higher aggressiveness and elevated mortality rates, requiring special attention.

Downloads

Download data is not yet available.

Author Biographies

Reyner Abrantes Stival, Pontifícia Universidade Católica de Goiás

Graduando do Departamento de Medicina da Pontifícia Universidade Católica de Goiás (PUC-Goiás) – Goiânia (GO), Brasil.

Luís Roberto de Almeida Martins, Pontifícia Universidade Católica de Goiás

Graduando do Departamento de Medicina da Pontifícia Universidade Católica de Goiás (PUC-Goiás) – Goiânia (GO), Brasil.

Junelle Paganini, Hospital Araújo Jorge

Biomédica. Mestre em Genética pela PUC-Goiás – Goiânia (GO), Brasil.

Gustavo Nogueira Caixeta, Hospital Araújo Jorge

Biomédico. Mestre em Biologia Molecular pela Universidade Federal de Goiás (UFG).Técnico do Laboratório de Imunoistoquímica do Hospital Araújo Jorge (HAJ)/Associação de Combate ao Câncer em Goiás (ACCG) – Goiânia (GO), Brasil.

Wilmar Jose Manoel, Hospital Araújo Jorge

Mastologista e Cirurgião Oncológico do HAJ/ACCG e do Centro Brasileiro de Radioterapia, Oncologia e Mastologia (CEBROM). Mestre em Genética pela PUC-Goiás. Doutor em Ciências da Saúde pela UFG – Goiânia (GO), Brasil.

Elbio Cândido de Paula, Universidade Federal de Goiás

Médico Patologista do Setor de Anatomia Patológica do HAJ/ACCG. Professor do Departamento de Patologia da UFG – Goiânia (GO), Brasil.

Flavio Monteiro Ayres, Universidade Estadual de Goiás

Docente da Universidade Estadual de Goiás (UEG) – Goiânia (GO), Brasil.

Antonio Márcio Teodoro Cordeiro Silva, Pontifícia Universidade Católica de Goiás

Docente do Departamento de Medicina da PUC-Goiás – Goiânia (GO), Brasil.

Diego Franciel Marques Mühlbeier, Hospital Araújo Jorge

Biomédico. Mestre em Genética pela PUC-Goiás – Goiânia (GO), Brasil

Vera Aparecida Saddi, Pontifícia Universidade Católica de Goiás

Docente da PUC-Goiás. Coordenadora do Laboratório de Transplante de Medula Óssea do HAJ/ACCG – Goiânia (GO), Brasil.

Published

2012-01-15

How to Cite

Stival, R. A., Martins, L. R. de A., Paganini, J., Caixeta, G. N., Manoel, W. J., Paula, E. C. de, … Saddi, V. A. (2012). Impact of triple negative phenotype on prognosis of breast cancer patients from a reference cancer unity in the central of Brazil. Revista Brasileira De Mastologia, 22(1), 6–12. Retrieved from https://revistamastology.emnuvens.com.br/rbm/article/view/57

Issue

Section

Original Article